Thursday, 13 June 2013- Nearly 2.5 million men currently live with prostate cancer in the United States, yet little is known about the association between diet after diagnosis and prostate cancer progression and overall mortality.

E. Richman and colleagues conducted a study to examine...

Wednesday, 12 June 2013- The FDA has rejected the oral VEGF receptor tyrosine kinase inhibitor tivozanib, intended for the treatment of renal cell carcinoma, according to the drug's developer. AVEO Oncology, of Cambridge, Mass., said it has received a Complete Response letter from the agency,...

Monday, 18 February 2013- The European School of Urology (ESU) organises a comprehensive post-graduate education programme during every annual congress of the European Association of Urology (EAU), and we are proud to continue this service keeping in mind the challenges and developments that make...

Tuesday, 14 February 2012- The iPhone App Store and Android Market feature the EAU Congress application (app), and congress participants are encouraged to download the application as it provides a handy and more convenient way to track events during the five-day meeting.

To be held from February...